NANOG and cancer: IGF-1 treatment induced the expression of NANOG and OCT4 and sphere formation in HepG2.2.15, Hep3B, and PLC5 cell lines, and inhibition of IGF-1R by shIGF-1R suppressed cancer stemness properties in these cell lines [134].